Antifungal susceptibility of Aspergillus fumigatus clinical isolates collected from various areas in Japan

Journal of Infection and Chemotherapy

Volumn 20, Issue 5, 2014, Pages 336-338

  Kikuchi, Kazuyo ^a   Watanabe, Akira ^a,b   Ito, Junko ^a   Oku, Yukio ^a   Wuren, Tuya ^a   Taguchi, Hideaki ^a   Yarita, Kyoko ^a   Muraosa, Yasunori ^a   Yahiro, Maki ^a   Yaguchi, Takashi ^a   Kamei, Katsuhiko ^a,b  

^a CHIBA UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Azole resistance; Beta tubulin gene; Itraconazole; Voriconazole

Indexed keywords

ITRACONAZOLE; VORICONAZOLE; ANTIFUNGAL AGENT;

ANTIFUNGAL RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; ASPERGILLUS FUMIGATUS; BROTH DILUTION; CANDIDA PARAPSILOSIS; FOLLOW UP; FUNGUS GROWTH; FUNGUS ISOLATION; JAPAN; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR PHYLOGENY; NONHUMAN; POINT MUTATION; QUALITY CONTROL; DRUG EFFECTS; HUMAN; MICROBIAL SENSITIVITY TEST;

ANTIFUNGAL AGENTS; ASPERGILLUS FUMIGATUS; DRUG RESISTANCE, FUNGAL; HUMANS; MICROBIAL SENSITIVITY TESTS;

EID: 84903597333     PISSN: 1341321X     EISSN: 14377780     Source Type: Journal    
DOI: 10.1016/j.jiac.2014.01.003     Document Type: Article

References (15)

1. Denning DW, Venkateswarlu K, Oakley KL, Anderson MJ, Manning NJ, Stevens DA, et al. Itraconazole resistance in Aspergillus fumigatus. Antimicrob Agents Chemother 1997;41: 1364-8.
2. Bueid A, Howard SJ, Moore CB, Richardson MD, Harrison E, Bowyer P, et al. Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009. J Antimicrob Chemother 2010;65: 2116-8.
3. Snelders E, van der Lee HA, Kuijpers J, Rijs AJ, Varga J, Samson RA, et al. Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism. PLoS Med 2008;5:e219.
4. Pfaller MA, Messer SA, Boyken L, Rice C, Tendolkar S, Hollis RJ, et al. In vitro survey of triazole cross-resistance among more than 700 clinical isolates of Aspergillus species. J Clin Microbiol 2008;46: 2568-72.
5. Alanio A, Sitterlé E, Liance M, Farrugia C, Foulet F, Botterel F, et al. Low prevalence of resistance to azoles in Aspergillus fumigatus in a French cohort of patients treated for haematological malignancies. J Antimicrob Chemother 2011;66: 371-4.
6. Escribano P, Peláez T, Muñoz P, Bouza E, Guinea J. Is azole resistance in Aspergillus fumigatus a problem in Spain? Antimicrob Agents Chemother 2013;57: 2815-20.
7. Yamaguchi H, Nisihimura Y, Uchida K, Takahashi C, Kawashima C, Hayashi M, et al. Nationwide survey of antifungal drug susceptibility of clinical fungal isolates in Japan for the Japan Antifungal Surveillance Program (JASP), 2005. J Jpn Soc Clin Microbiol 2009;19: 128-41.
8. Tashiro M, Izumikawa K, Minematsu A, Hirano K, Iwanaga N, Ide S, et al. Antifungal susceptibilities of Aspergillus fumigatus clinical isolates obtained in Nagasaki, Japan. Antimicrob Agents Chemother 2012;56: 584-7.
9. Yaguchi T, Horie H, Tanaka R, Matsuzawa T, Ito J, Nishimura K. Molecular phylogenetics of multiple genes on Aspergillus section Fumigati isolated from clinical specimens in Japan. Nihon Ishinkin Gakkai Zasshi (Jpn J Med Mycol) 2007;48: 37-46.
10. Clinical and Laboratory Standards Institute Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Wayne, PA: CLSI; 2008. Approved standard-Second Edition Clinical and Laboratory Standards Institute document M38-A2.
11. Arendrup MC, Cuenca-Estrella M, Lass-Flörl C, Hope WW, European Committee on Antimicrobial Susceptibility Testing Subcommittee on Antifungal Susceptibility Testing (EUCAST-AFST). EUCAST technical note on Aspergillus and amphotericin B, itraconazole, and posaconazole. Clin Microbiol Infect 2012;18:E248-50.
12. Hope WW, Cuenca-Estrella M, Lass-Flörl C, Arendrup MC, European Committee on Antimicrobial Susceptibility Testing-Subcommittee on Antifungal Susceptibility Testing (EUCAST-AFST). EUCAST technical note on voriconazole and Aspergillus spp. Clin Microbiol Infect 2013;19:E278-80.
13. Camps SM, van der Linden JW, Li Y, Kuijper EJ, van Dissel JT, Verweij PE, et al. Rapid induction of multiple resistance mechanisms in Aspergillus fumigatus during azole therapy: a case study and review of the literature. Antimicrob Agents Chemother 2012;56: 10-6.
14. Arendrup MC, Mavridou E, Mortensen KL, Snelders E, Frimodt-Møller N, Khan H, et al. Development of azole resistance in Aspergillus fumigatus during azole therapy associated with change in virulence. PLoS One 2010;5:e10080.
15. Howard SJ, Arendrup MC. Acquired antifungal drug resistance in Aspergillus fumigatus: epidemiology and detection. Med Mycol 2011;49(Suppl. 1):S90-5.